Oct 21, 2020 (The Expresswire) -- Global Radiopharmaceutical Market 2020 Research Report share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Radiopharmaceutical submarkets, with respect to key regions (along with their respective key countries). It analyzes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
Get a Sample Copy of the report - https://www.marketreportsworld.com/enquiry/request-sample/12208794
Global Radiopharmaceutical Market report consumption (value and volume) by key regions/countries, product type and application and forecast to 2023. Radiopharmaceutical market understand the structure by identifying its various subsegments. Focuses on the key global Radiopharmaceutical manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. Radiopharmaceutical with respect to individual growth trends, future prospects, and their contribution to the total market.
Radiopharmaceutical Market report studies the world market size of Radiopharmaceutical in key regions like North America, Europe, Asia Pacific, Central and South America and Mideast and Africa, focuses on the consumption of Radiopharmaceutical in these regions. The various contributors concerned within the price chain of Radiopharmaceutical embrace makers, suppliers, distributors, intermediaries, and customers.
Enquire before purchasing this report - https://www.marketreportsworld.com/enquiry/pre-order-enquiry/12208794
Radiopharmaceuticals are those radioisotopes when used for diagnosis or therapy, typically stimulate no physiological response from the patient. They are the unique medicinal formulations containing radioisotopes which can be used diagnosis and treatment of various chronic diseases. Radioisotopes play a very crucial part in the medical diagnostic procedures. In combination with imaging devices which record the gamma rays emitted from inside, healthcare professionals can study the dynamic processes taking place in various parts of the body.
Increasing prevalence of chronic diseases which indicates the growing need for early diagnosis and treatment is one of the major factors responsible for the growth of the market. Moreover, rising expenditure in oncology and growing emphasis on cancer management has also accelerated the market growth owing to the need for new diagnostic and treatment options for common as well as rare cancers.
Both diagnostic and treatment characteristics of radiopharmaceutical driving the market growth. As per World Nuclear Association, in a quarter of the world population, about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this. Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs and used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells.
The key players for the Radiopharmaceutical market are Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Siemens, Avid Radiopharmaceuticals, IBA Dosimetry and Others.
Increasing Prevalence of Chronic Diseases is also driving the growth of the market. According to the World Cancer Research Fund International, in 2015, cancer was responsible for 8.8 million deaths and is the second leading cause of death across the globe. As per the American Heart Association, in 2017, about 92.1 million Americans were diagnosed with cardiovascular disease.Additionally, as per the National Research University Higher School of Economics, tension-type headaches (about 1,500 million cases), migraine (about 1,000 million), medication overuse headaches (about 60 million), and Alzheimer's disease and other dementias (about 46 million cases) are the most common type of neurological disorders in 2015.
Whereas certain factors such as the high cost of radiopharmaceuticals is restraining the growth of the market. As per National Research Universal (NRU), the cost of some nuclear medicine have increased by as much as 1,000 percent recently. Similarly, according to the research, the overall financial cost for the underutilized radiopharmaceutical materials due to canceled and rescheduled procedures for 142 patients was about 39,760 US dollar. The daily financial loss from these cancellations was between USD 560 to USD 1120
The global radiopharmaceuticals market is expected to reach to the market value of USD 10,473.88 million by 2023 from USD 5,841.22 million in 2016 and have a CAGR of 8.7% during the forecast period, 2017â€“2023.
On the basis of type, the market for Radiopharmaceutical is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals By type, the market for diagnostic type radiopharmaceuticals accounted for the largest market share in 2017.
On the basis of type of tests, the market for Radiopharmaceutical is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. By type of tests, the market for intermediate Radiopharmaceutical accounted for the largest market share in 2017.The global Radiopharmaceutical, by application, is segmented into oncology, cardiology, neurology, urology, and others. By application, the market for Oncology accounted for the largest market share in 2017.The global Radiopharmaceutical, by route of administration, is segmented into oral, intravenous and other route of administration. The intravenous segment holds the largest market share in global Radiopharmaceutical, by route of administration.On the basis of the route of administration, the global Radiopharmaceutical market is segmented into intravenous, intravitreal, and others. The intravitreal segment dominates the global Radiopharmaceutical market. The global Radiopharmaceutical, on the basis of end-user, is segmented into hospitals, diagnostic centers, research institutes and others. Hospitals hold the largest market share in the global Radiopharmaceutical market.
To provide historical and forecast revenue of the market segments and sub-segments with respect to â€“ regional markets and their countries
To provide insights into factors influencing and affecting the market growth
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
To provide economic factors that influence the global Radiopharmaceutical market
Pharmaceutical and Medical Device Industries
Medical Research Institutes
Key Executive (CEO and COO) and Strategy Growth Manager
The major market players in the global Radiopharmaceutical market are F Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Siemens, Avid Radiopharmaceuticals, IBA Dosimetry and Others.Siemens accounted for more than 13.2% share of the global Radiopharmaceutical MarketBased on type of tests, Bone Scan segment accounts the largest market share which is expected to reach USD 2,513.68 million by 2023 from USD 1,470.34 million in 2016Based on application, the market for oncology is expected to reach USD 4,747.76 million by 2023Based on route of administration, intravenous segment was the largest segment in the year 2017 and is expected to reach USD 7,316.86 million by 2023 from USD 3,995.90 million in 2016On the basis of region, Asia pacific region is projected to be the fastest growing region, at a CAGR of 9.3% during the forecast period.
The report also covers regional analysis
oRest of Western Europe
oRepublic of Korea
oRest of Asia Pacific
The Middle East and Africa
Key Point Involved in the Report: -
Radiopharmaceutical Market Forecast by regions, type and application, with sales and revenue, from 2020 to 2023.
Radiopharmaceutical Market Share, distributors, major suppliers, changing price patterns and the supply chain of raw materials is highlighted in the report.
Radiopharmaceutical Market Size (sales, revenue) forecast by regions and countries from 2020 to 2023 of Radiopharmaceutical industry.
The global Radiopharmaceutical market Growth is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2023. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Radiopharmaceutical Market Trend for Development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.
Radiopharmaceutical Market Report also mentions market share accrued by each product in the Radiopharmaceutical market, along with the production growth.
Purchase this Report (Price 4450 USD for Single User License) - https://www.marketreportsworld.com/purchase/12208794
Radiopharmaceutical Market provides sizing and growth opportunities for the period 2020-2023. Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market. Report Includes a detailed analysis of growth drivers, challenges, and investment opportunities. Delivers a complete overview of segments and the regional outlook of the market. Radiopharmaceutical Market Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.
Lastly, this report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market shares.
Total Chapters in Radiopharmaceutical Market Report are:
Chapter 1 Overview of Radiopharmaceutical Market
Chapter 2 Global Market Status and Forecast by Regions
Chapter 3 Global Market Status and Forecast by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
Chapter 10 Market Driving Factor Analysis of Low End Servers
Chapter 11 Radiopharmaceutical Market Competition Status by Major Manufacturers
Chapter 12 Radiopharmaceutical Major Manufacturers Introduction and Market Data
Chapter 13 Upstream and Downstream Market Analysis of Radiopharmaceutical Market
Chapter 14 Cost and Gross Margin Analysis of Radiopharmaceutical Market
Detailed TOC of Global Radiopharmaceutical Market Analysis and Forecast
1 Executive Summary
2 Market Dynamics
2.1 Market Growth Factors
2.1.1 Rising Security and Safety Concern
2.1.2 Radiopharmaceutical in Developing Countries
2.1.3 Enhanced Business Productivity
2.2 Market Restraints
2.3 Radiopharmaceutical Supply Chain Process
2.4 Porter’s Five Forces Analysis
3 Global Radiopharmaceutical Market, By Type
4 Global Radiopharmaceutical Market, By Component
4.2.1 Radiopharmaceutical Components